Back to GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC

RARERARE
Showing 8 of 31 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLCGEODE CAPITAL MANAGEMENT, LLC's holdings in ULTRAGENYX PHARMACEUTICAL IN

GEODE CAPITAL MANAGEMENT, LLC holds 2.6M shares of RARE (ULTRAGENYX PHARMACEUTICAL IN), worth $86.1M as of 2026-Q2. The position was increased (+39.4% shares). RARE represents 0.0% of GEODE CAPITAL MANAGEMENT, LLC's portfolio.

Current Value

$86.1M

Current Shares

2.6M

Total Value Change

-$1.2M

Total Shares Change

+1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
2.6M
+39.4%
$86.1M0.0%$33.39
39
2026-Q1
Increased
1.8M
+0.6%
$38.8M0.0%$22.07
29
2025-Q4
Increased
1.8M
+16.3%
$42.3M0.0%$22.78
34
2025-Q3
Decreased
1.6M
-7.7%
$47.6M0.0%$30.36
0
2025-Q2
Increased
1.7M
+4.0%
$62.3M0.0%$36.52
31
2025-Q1
Increased
1.6M
+5.4%
$59.6M0.0%$37.82
31
2024-Q4
Decreased
1.6M
-0.5%
$65.8M0.0%$42.27
0
2024-Q3
Increased
1.6M
+4.4%
$87.3M0.0%$54.43
31

Other major holders of RARE: Capital Research Global Investors, BNP PARIBAS FINANCIAL MARKETS, Capital International Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used